| Literature DB >> 31875175 |
Golpar Radafshar1, Marziyeh Movahedi Amiri2.
Abstract
STATEMENT OF THE PROBLEM: Information on patient-centered outcomes of periodontal disease and the impact of different periodontal treatment phases on the life quality of periodontal patients is limited.Entities:
Keywords: Dental scaling ; Periodontal disease-therapy; Quality of life ; Root planning ; Surgery ; Chronic periodontitis
Year: 2019 PMID: 31875175 PMCID: PMC6890818 DOI: 10.30476/DENTJODS.2019.77748.
Source DB: PubMed Journal: J Dent (Shiraz) ISSN: 2345-6418
Demographic characteristics of the sample (N=38) and their significance upon the OHIP-35-IR score over the time
| Variable | Measurements | P | P |
|---|---|---|---|
| Age (years), mean ± SD (range) | 40.3±11.9 (18-60) | 0.23 | 0.61 |
| Sex, n (%) | |||
| Females | 24(63.2) | 0.07 | 0.33 |
| Males | 14(36.8) | 0.12 | 0.29 |
| Monthly income | - | ||
| Low, Middle, High(Toman) | 0/17/21 | - | - |
| Smoking, n (%) | |||
| Smokers | 5(13.1) | - | - |
| Non-smokers | 33(86.9) | - | - |
| Educational level (%) | |||
| BD/Diploma/AD, n (%) | 0/9(23.6)/29(76.3) | - | - |
| PPD | 3.68±1.4 | 0.07 | - |
| CAL | 4.51±1.5 | 0.28 | - |
| BI (%) | 76.14±18.75 | 0.05 | 0.03 |
Low:900000, Middle:900000-3000000, High:>3000000 Toman: Iranian currency
Below High School Diploma(BD), Above High School Diploma(AD)
Non-adjusted linear model
Multivariate model adjusted for age, gender, and periodontal variables
Comparison of mean and SD of OHIP-35-IR subdomains at baseline, phase I, and phase II
| OHIP- 35 Subscales | Baseline (N=38) | Phase I(N=38) | Phase II (N=38) |
| |||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | Baseline/Phase I | Phase I/II | Baseline/Phase II | |
| Functional limitation | 13.23 | 3.11 | 9.62 | 3.70 | 10.32 | 3.55 | <0.001 | 0.146 | <0.001 |
| Physical pain | 13.54 | 4.01 | 11.93 | 3.04 | 11.43 | 3.34 | 0.01 | 0.42 | 0.002 |
| Psychological discomfort | 19.06 | 4.94 | 12.42 | 5.73 | 12.77 | 6.07 | <0.001 | 0.37 | <0.001 |
| Physical disability | 11.36 | 3.65 | 11.65 | 2.74 | 11.72 | 2.44 | 0.56 | 0.67 | 0.15 |
| Psychological disability | 9.13 | 4.84 | 8.06 | 3.49 | 7.75 | 2.79 | 0.58 | 0.20 | 0.22 |
| Social disability | 7.50 | 4.53 | 8.01 | 3.76 | 8.01 | 3.76 | 0.53 | 0.99 | 0.50 |
| Handicap | 10.49 | 4.45 | 8.53 | 2.83 | 7.65 | 2.95 | 0.01 | 0.13 | 0.001 |
| Total score | 89.25 | 19.26 | 75.63 | 17.15 | 74.22 | 15.46 | <0.001 | 0.66 | 0.001 |
Repeated measures ANOVA and Greenhouse-Geisser test
Figure1OHIP-35 subscales: Comparison of means at baseline, post non-surgical, and post-surgical treatments
OHIP (total and subscales) change score and effect size (n=38)
| OHIP | Change score | P value | Effect size (w2) | Effect size threshold | ||
|---|---|---|---|---|---|---|
| Mean | SD | |||||
| Functional limitation | BL | 3.55 | 3.81 | <0.001 | 0.926 | Large |
| BL to P II | 2.73 | 3.01 | <0.001 | 0.786 | Moderate | |
| P I to II | -1.27 | 4.62 | 0.1 | 0.264 | small | |
| Physical pain | BL to P I | 1.61 | 3.70 | 0.01 | 0.433 | Moderate |
| BL to P II | 2.33 | 3.65 | 0.002 | 0.612 | Moderate | |
| P I to II | 0.38 | 2.51 | 0.4 | 0.144 | Small | |
| Psychological discomfort | BL to P I | 6.63 | 5.74 | <0.001 | 1.162 | Large |
| BL to P II | 6.00 | 6.74 | <0.001 | 0.895 | Large | |
| P I to II | -1.05 | 6.32 | 0.3 | 0.16 | Small | |
| Physical disability | BL to P I | -0.36 | 3.25 | 0.5 | 0.094 | Small |
| BL to P II | -1.00 | 4.03 | 0.1 | 0.256 | small | |
| P I to II | -0.36 | 3.63 | 0.6 | 0.076 | Small | |
| Psychological disability | BL to P I | 0.48 | 4.41 | 0.6 | 0.089 | Small |
| BL to P II | 1.03 | 4.51 | 0.2 | 0.217 | small | |
| P I to II | 0.95 | 4.12 | 0.2 | 0.228 | small | |
| Social disability | BL to P I | -0.55 | 5.14 | 0.5 | 0.102 | Small |
| BL to P II | -0.55 | 5.14 | 0.534 | 0.102 | Small | |
| P I to II | 0.00 | 0.00 | 0.9 | 0.000 | Small | |
| Handicap | BL to P I | 1.76 | 4.13 | 0.01 | 0.424 | Moderate |
| BL to P II | 2.51 | 4.05 | 0.001 | 0.626 | Moderate | |
| P I to II | 0.87 | 3.01 | 0.1 | 0.273 | small | |
| OHIP-35 | BL to P I | 13.64 | 16.80 | <0.001 | 0.803 | Large |
| BL to P II | 12.25 | 18.91 | 0.001 | 0.661 | Moderate | |
| P I to II | -1.46 | 17.50 | 0.6 | 0.079 | Small | |
Omega squared
small (≤ 0.2), moderate (0.3-0.7) or large (≥0.8) effect [Cohen (36)]
BL: Baseline
Phase one
Phase two